AmKor Pharma
AmKor Pharma, Inc. (AmKor) is a biopharmaceutical
company with a clinical stage focus on products that treat the body’s
response to injury. We operate our business with minimal infrastructure,
contracting out most activities to contract research organizations, manufacturers
and testing labs. Reducing infrastructure costs reduces financial risk
and is practical for developmental stages of pharmaceutical research.
Spotlight
Our lead product is Neu2000, a multi-mechanism neuroprotectant compound being developed initially for the treatment of ischemic stroke and cardiac arrest.Publications
View our latest publications.